Reuters logo
2 个月前
BRIEF-Endocyte form 4 discloses CEO's 44,285 stock options fully vested on May 31, immediately exercisable
2017年6月2日 / 下午12点32分 / 2 个月前

BRIEF-Endocyte form 4 discloses CEO's 44,285 stock options fully vested on May 31, immediately exercisable

1 分钟阅读

June 2 (Reuters) - Endocyte Inc

* Endocyte Inc form 4 discloses that CEO Michael Sherman's 44,285 stock options (right to buy) fully vested on may 31 and immediately exercisable - sec filing Source text (bit.ly/2rytsCJ) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below